Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Vaginal contraceptive rubber diaphragm type C arcing spring 60-95mm
21040000421
|
Vaginal contraceptive rubber diaphragm type C arcing spring 60-95mm | Contraceptive Devices | Appliances | No data available |
|
Valaciclovir 100mg/5ml oral suspension
0503021A0AAAEAE
|
Valaciclovir | Valaciclovir | Infections | No data available |
|
Valaciclovir 250mg/5ml oral suspension
0503021A0AAAFAF
|
Valaciclovir | Valaciclovir | Infections | No data available |
|
Valaciclovir 25mg/1ml oral suspension
0503021A0AAADAD
|
Valaciclovir | Valaciclovir | Infections | No data available |
|
Valclair 10mg suppositories
0401020K0BKAABB
|
Valclair | Diazepam | Central Nervous System | No data available |
|
Valdecoxib 10mg tablets
1001010ALAAAAAA
|
Valdecoxib | Valdecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Valdecoxib 20mg tablets
1001010ALAAABAB
|
Valdecoxib | Valdecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Valdecoxib 40mg tablets
1001010ALAAACAC
|
Valdecoxib | Valdecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Valderma cream
1310011T0BBAAAA
|
Valderma (Cream) | Potassium hydroxyquinoline sulphate | Skin | No data available |
|
Valdic 100 Retard tablets
1001010C0CHAAAF
|
Valdic | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Valdic 75 Retard tablets
1001010C0CHABAL
|
Valdic | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Valerian 62.5mg / Hops extract 33.4mg tablets
091200000AAFPFP
|
Generic compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Valerian root extract 26mg tablets
091200000AAGBGB
|
Generic compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Valerian root tincture
190606000BCWEA0
|
Proprietary compound preparation BNF 1906060 | Other tincture preparations | Other Drugs and Preparations | No data available |
|
Valeriana tincture
190606000BCXFA0
|
Proprietary compound preparation BNF 1906060 | Other tincture preparations | Other Drugs and Preparations | No data available |
|
Valganciclovir 570mg/5ml oral liquid
0503022B0AAAEAE
|
Valganciclovir hydrochloride | Valganciclovir hydrochloride | Infections | No data available |
|
Valine 50mg/5ml oral solution
091101000AADZDZ
|
Generic compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
Valine powder
091101000AAGAGA
|
Generic compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
Valket 200 Retard capsules
1001010L0BNAAAJ
|
Tiloket | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Vallergan 10mg tablets
0304010Y0BBAAAD
|
Vallergan | Alimemazine tartrate | Respiratory System | No data available |
|
Vallergan 7.5mg/5ml syrup
0304010Y0BBABAB
|
Vallergan | Alimemazine tartrate | Respiratory System | No data available |
|
Vallergan Forte 30mg/5ml syrup
0304010Y0BBACAC
|
Vallergan | Alimemazine tartrate | Respiratory System | No data available |
|
Valoid 50mg/1ml solution for injection ampoules
0406000G0BBAAAA
|
Valoid (Parenteral) | Cyclizine lactate | Central Nervous System | No data available |
|
Valpeda 0.3% cream
1310020K0BBAAAA
|
Valpeda | Halquinol | Skin | No data available |
|
Valpiform gluten free bread mix
090401030BIABAK
|
Valpiform (Gluten free mix) | Gluten free mixes | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.